切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2008, Vol. 04 ›› Issue (01) : 14 -17. doi: 10.3877/cma.j.issn.1673-5250.2008.01.106

论著

妊娠合并人类免疫缺陷病毒孕妇围生期管理模式的探讨
庆山, 阳豫, 刘文兴, 梁一凡, 徐慧芳, 蔡卫平   
  1. 广州市妇婴医院(广州,510180)
    广州市疾病预防控制中心
    广州市第八人民医院
  • 出版日期:2008-02-01
  • 基金资助:
    中美合作适宜性健康教育项目、广州市医药卫生科技资助项目(2007-YB-080)

To study the management model for pregnant women with human immunodeficiency virus infection in their perinatal period

Qing-shan XUAN, Yu YANG, Wen-xing LIU, Yi-fan LIANG, Hui-fang XU, Wei-ping CAI   

  1. Obstetrics and Gynecology of Guangzhou Maternal and Infant Hospital. Guangzhou 510180, China
  • Published:2008-02-01
引用本文:

庆山, 阳豫, 刘文兴, 梁一凡, 徐慧芳, 蔡卫平. 妊娠合并人类免疫缺陷病毒孕妇围生期管理模式的探讨[J/OL]. 中华妇幼临床医学杂志(电子版), 2008, 04(01): 14-17.

Qing-shan XUAN, Yu YANG, Wen-xing LIU, Yi-fan LIANG, Hui-fang XU, Wei-ping CAI. To study the management model for pregnant women with human immunodeficiency virus infection in their perinatal period[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2008, 04(01): 14-17.

目的

通过对妊娠合并人类免疫缺陷病毒(human immunodeficiency virus,HIV)孕妇围生期综合性干预,探索有效阻断HIV母婴传播的模式。

方法

选择1999年7月至2006年12月广州市妇婴医院收治的67例妊娠合并HIV孕妇为研究对象。通过孕期医学咨询及同伴教育后,33例孕妇选择终止妊娠(口服米非司酮+米索前列醇);34例孕妇选择继续妊娠(4例为临产入院),对其进行孕期保健、同伴教育、服用抗逆转录病毒药物、择期剖宫产及产后新生儿人工喂养等综合干预。

结果

33例选择终止妊娠的孕妇中,早孕23例和中孕8例孕妇,口服药物后,全部完全性流产;另外2例采取羊膜腔内注射依沙吖啶(雷佛奴尔)引产,因胎膜残留,行清宫术。34例选择继续妊娠的孕妇中,除临产入院的4例外,其余30例全程接受干预处理,CD4+水平明显上升,CD4+/CD8+上升,Hb水平无明显下降,HIV-RNAcopy明显下降。30例全程接受干预所产新生儿18个月进行第2次HIV IgG检测(2例尚未到时间)时,27例呈阴性,1例呈阳性。4例临产入院所产新生儿,2例HIV IgG呈阳性,1例呈阴性,1例失访。

结论

妊娠合并HIV孕妇,在围生期有效的干预措施下,不但能对HIV孕产妇进行有效管理,失访率低,而且能有效阻断HIV母婴垂直传播。

Objective

To study the effective model for the prevention of mother-to-infant transmission of HIV.

Methods

67 pregnant women with human immunodeficiency virus(HIV) infection (July 1999 to December 2006 in Guangzhou Maternal and Infant Hospital) were enrolled in this programme. After counseling and companion education, 33 women elected to terminate the pregnancy, and 34 women elected to continue the pregnancy. All patients were treated appropriately.

Results

31 cases were completely aborted with mifepristone plus misoprostol. 2 cases were aborted with invasive rivanol plus surgical curettage. 34 cases who elected to continue the pregnancy, among 30, whoes levels of CD4+ and the ratio of CD4+/CD8+ were raised, the level of hemoglobin was in the normal range, and copies of HIV-RNA were reduced sharply. 28 neonates whose age were at 18 months were detected for HIV-IgG, negative for IgG was found in 27, and positive in 1. 4 neonates whose mothers admitted to the hospital just before labor, 2 neonates were detected to be positive for IgG, 1 neonate negative and 1 lost to follow-up.

Conclusion

Under the preventive measures and intervention for HIV pregnant women of childbearing age, the HIV vertical transmission from mother-to-infants can be prevented effectivly.

1 马桂林,代涛.中国艾滋病流行趋势的分析.中华流行病学杂志,2006, 25(7):627-628.
2 王临虹主编. 预防艾滋病母婴传播. 北京:人民卫生出版社,2006, 25-122.
3 Harry TO, Bukbuk DN, Idrisa A, et al. HIV infection among pregnant women. A worsening situation in Maiduguri, Nigeria. Trop Geogr Med, 1994, 46(1):46-47.
4 王晨虹. 米非司酮在引产中的应用. 中国实用妇科与产科杂志,2002, 8(5):267.
5 Shaffer N, Roongpisuthipong A, Siriwasin W, et al. Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group. J Infect Dis, 1999, 179(3):590-599.
6 Kid C,Rudin C, Siegrist CA, et al. Prevention of vertical HIV transmission:Additive protective effect of elective cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study Group. AIDS, 1998, 12(2):205-206.
7 The European Mode of Delivery Collaboration. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission:A randomised clinical trial. Lancet, 1999, 353(9158):1035-1039.
8 Miotti PG, Taha TE, Kumwenda NT, et al. HIV transmission through breasrfeeding:A study in Melawi. JAMA, 1999, 282(8):744-749.
9 Van de Perre P. Transmission of human immunodeficiency virus type 1 through breast-feeding:How can it be prevented? J Infect Dis, 1999,179(suppl 3):S405-406.
10 Calleja JM, Walker N, Cuchi P, et al. Status of the HIV/AIDS epidemic and methods to monitor it in the Latin America and Caribbean region. AIDS, 2002, 16(Suppl 3):3-12.
11 Mostad SB, Overbaugh J, DeVange DM, et al. Hormonal contraception vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet, 1997, 350(9082):922-927.
[1] 杨桂清, 孟静静. 哺乳期亚临床乳腺炎的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 376-379.
[2] 吴茜, 邓力, 练士贤, 张华, 江颖, 张宏伟. 伴人类免疫缺陷病毒感染乳腺癌患者的临床病理特征与预后的相关性研究[J/OL]. 中华乳腺病杂志(电子版), 2023, 17(03): 151-156.
[3] 丁兴欢, 王小永, 李风志, 梁博, 冯恩山. 颅内外血管搭桥联合贴敷治疗慢性颈内动脉闭塞的人类免疫缺陷病毒感染者一例及文献复习[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 314-319.
[4] 熊企秋, 邢卉春, 李宝亮, 王杨, 贾哲, 张珂, 黄容海, 蒋力. 人类免疫缺陷病毒感染对肛瘘患者接受切开挂线术治疗预后的影响[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 303-308.
[5] 戚仕轩, 阮连国. 人类免疫缺陷病毒感染快速启动抗逆转录病毒治疗研究及模式探索[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(04): 193-199.
[6] 曾雪灵, 杨思园, 常宇飞, 赵红心, 王凌航. 176例人类免疫缺陷病毒合并肺部感染者呼吸道病原体特点与免疫学特征[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(03): 142-148.
[7] 叶俊杰, 胡波涌. 人类免疫缺陷病毒感染者限期骨折内植物手术并发症的影响因素[J/OL]. 中华实验和临床感染病杂志(电子版), 2023, 17(06): 423-430.
[8] 陈珂, 孙挥宇. 人类免疫缺陷病毒感染/获得性免疫缺陷综合征患者非感染性相关眼病研究进展[J/OL]. 中华实验和临床感染病杂志(电子版), 2023, 17(06): 395-399.
[9] 张玉, 薛文瑞, 王鑫, 李旭瑜, 王旭东, 袁鹏飞, 梁雨润, 韩志兴, 张海建, 刘庆军, 纪世琪. 人类免疫缺陷病毒感染合并膀胱癌14例临床特点[J/OL]. 中华实验和临床感染病杂志(电子版), 2023, 17(05): 354-358.
[10] 崔贵香, 丁晓燕, 褚盈晖, 孙代, 吴海燕, 陈京龙. 57例人类免疫缺陷病毒感染合并Burkkit淋巴瘤患者的临床分析[J/OL]. 中华实验和临床感染病杂志(电子版), 2023, 17(02): 102-109.
[11] 袁瑞, 胡文佳, 桂希恩, 严亚军, 冯玲, 柯亨宁, 熊勇, 杨蓉蓉. 淋巴细胞精细分型检测在人类免疫缺陷病毒感染者/获得性免疫缺陷综合征患者中的应用[J/OL]. 中华实验和临床感染病杂志(电子版), 2023, 17(02): 84-91.
[12] 李倩, 邓莉平, 陈果, 张忠威, 莫平征, 胡文佳, 陈良君, 张捷, 张永喜, 杨蓉蓉, 熊勇. 宏基因组二代测序在获得性免疫缺陷综合征合并中枢神经系统感染中的临床应用[J/OL]. 中华实验和临床感染病杂志(电子版), 2023, 17(01): 24-31.
[13] 张燕珍, 王锡携, 文小兰. 血清巨噬细胞迁移抑制因子对活动性肺结核分诊检测的意义[J/OL]. 中华肺部疾病杂志(电子版), 2023, 16(02): 200-202.
[14] 王希岗, 张波, 李鸣, 高敏, 薛建新. 神经外科手术部位感染在HIV感染者与非HIV感染者中的临床差异[J/OL]. 中华神经创伤外科电子杂志, 2023, 09(04): 228-233.
[15] 李佳佳, 李凌华, 吕诗韵, 冯凯, 刘琳珊, 钟海丹, 颜婵, 刘聪. 广州市病毒学抑制失败HIV/AIDS患者的耐药特征及影响因素分析[J/OL]. 中华卫生应急电子杂志, 2024, 10(04): 207-212.
阅读次数
全文


摘要